JP2022517531A5 - - Google Patents

Info

Publication number
JP2022517531A5
JP2022517531A5 JP2021537075A JP2021537075A JP2022517531A5 JP 2022517531 A5 JP2022517531 A5 JP 2022517531A5 JP 2021537075 A JP2021537075 A JP 2021537075A JP 2021537075 A JP2021537075 A JP 2021537075A JP 2022517531 A5 JP2022517531 A5 JP 2022517531A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
mscs
hscs
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021537075A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022517531A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/014041 external-priority patent/WO2020150580A1/en
Publication of JP2022517531A publication Critical patent/JP2022517531A/ja
Publication of JP2022517531A5 publication Critical patent/JP2022517531A5/ja
Pending legal-status Critical Current

Links

JP2021537075A 2019-01-18 2020-01-17 神経学的疾患のための二重幹細胞治療 Pending JP2022517531A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962794041P 2019-01-18 2019-01-18
US62/794,041 2019-01-18
PCT/US2020/014041 WO2020150580A1 (en) 2019-01-18 2020-01-17 Dual stem cell therapy for neurological conditions

Publications (2)

Publication Number Publication Date
JP2022517531A JP2022517531A (ja) 2022-03-09
JP2022517531A5 true JP2022517531A5 (cg-RX-API-DMAC7.html) 2022-10-21

Family

ID=71614511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021537075A Pending JP2022517531A (ja) 2019-01-18 2020-01-17 神経学的疾患のための二重幹細胞治療

Country Status (5)

Country Link
US (1) US20220072050A1 (cg-RX-API-DMAC7.html)
EP (1) EP3911342A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022517531A (cg-RX-API-DMAC7.html)
CA (1) CA3127090A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020150580A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019071036A1 (en) * 2017-10-05 2019-04-11 The Board Of Trustees Of The Leland Stanford Junior University CONDUCTIVE POLYMER IMPLANT, COMBINING ELECTRICAL AND CHEMICAL STIMULATION TO IMPROVE NEURONAL RECOVERY

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050069597A1 (en) * 1999-07-01 2005-03-31 Thompson Ronald J. Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of alprostadil for the treatment of female sexual dysfunction
JP4741189B2 (ja) * 2002-02-08 2011-08-03 ユニヴァーシティ オブ サウス フロリダ 増殖した細胞系およびその使用方法
US7470538B2 (en) * 2002-12-05 2008-12-30 Case Western Reserve University Cell-based therapies for ischemia
WO2004090112A2 (en) * 2003-04-01 2004-10-21 United States Of America Department Of Veteran's Affairs Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
US8609082B2 (en) * 2005-01-25 2013-12-17 Bio Control Medical Ltd. Administering bone marrow progenitor cells or myoblasts followed by application of an electrical current for cardiac repair, increasing blood supply or enhancing angiogenesis
WO2009011546A2 (en) * 2007-07-16 2009-01-22 Catholic University Industry Academic Cooperation Foundation Method for promoting the self-renewal of adult stem cells using mesenchymal stromal cells
JP6998768B2 (ja) * 2015-08-28 2022-02-10 ロート製薬株式会社 Ror1陽性の間葉系幹細胞及びその調製方法、ror1陽性の間葉系幹細胞を含む医薬組成物及びその調製方法、並びにror1陽性の間葉系幹細胞を用いる疾患の予防又は治療方法
EP3231434A1 (en) * 2016-04-14 2017-10-18 Fundacio Centre de Regulacio Genomica Method of treatment of parkinsonism

Similar Documents

Publication Publication Date Title
TWI746588B (zh) 以自成體幹細胞分離之擬胞外體奈米囊胞作為促進血管生成活性之組成物的用途及其製造方法
Bradley et al. Correlation of prostaglandin release from the cerebral cortex of cats with the electrocorticogram, following stimulation of the reticular formation
JP2025503791A (ja) 毛包修復タンパク質組成物及びその作製方法とその使用
CN112891375B (zh) 一种神经干细胞外泌体经鼻吸收药物的制备方法及应用
KR102591782B1 (ko) 뇌신경계질환 예방 또는 치료용 약학적 조성물
KR20150102957A (ko) Hmgb1 단편을 이용한 척수 손상에 대한 신규 치료법
Satani et al. Is immunomodulation a principal mechanism underlying how cell-based therapies enhance stroke recovery?
WO2019006734A1 (zh) (+)-2-莰醇在制备促鞘氨醇激酶-1和/或bdnf表达上调的药物中的应用
JPS6130521A (ja) 末梢神経障害の疼痛治療用ガングリオシド混合物
CN112159793B (zh) 人脱落乳牙牙髓干细胞的应用
Chen et al. Immune characteristics of olfactory ensheathing cells and repair of nerve injury
Li et al. A promising strategy for repairing tissue damage: mitochondria transfer from mesenchymal stem cells
Gasparyan et al. Influence of low level laser radiation on migration of stem cells
CN105287657A (zh) 一种治疗癫痫病的银杏叶提取物及其用途
WO2016041192A1 (zh) 藁本内酯的应用
Qu et al. Induction of substantial myocardial regeneration by an active fraction of the Chinese herb Rosa laevigata Michx
CN115887430A (zh) 甘草查尔酮a在免疫细胞增殖上的应用
Gasparyan et al. Influence of low level laser radiation on migration of stem cells
KR102551880B1 (ko) 부신피질자극호르몬분비호르몬을 유효성분으로 포함하는 신경세포구 형성 촉진용 조성물
JP2016523975A (ja) 穿通性頭部外傷の処置におけるn−アセチルシステインアミドの使用
WO2016073801A1 (en) Low-level laser irradiation of stimulated human stem cells
He Research progress and prospects of mesenchymal stem cells for neu-rodegenerative disease treatment
CN117925501B (zh) 一种桔梗外泌体及其在制备治疗肺系疾病药物中的应用
TWI645083B (zh) 篩選抑制發炎反應及血管保護活性物質之方法
CN112957351B (zh) ω-3多不饱和脂肪酸和L-丝氨酸在制备乳腺癌化疗药物的增效剂中的应用